Company intelligence / Profile preview

MEDFREE

Newark, California, United Statesmedfreeinc.com ↗

Ownership: Private
Development stage: Preclinical

Overview

MEDFREE is developing a minimally invasive medical device for the percutaneous treatment of mitral and tricuspid valve regurgitation using the Transcutaneous Edge-to-Edge Repair (TEER) technique. The company has received support from the National Heart, Lung, and Blood Institute (NHLBI) and the National Science Foundation for its research

Therapeutic areas: Cardiovascular
Modalities: DeviceTranscatheter valve repair system (Transcutaneous Edge-to-Edge Repair)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MEDFREE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEDFREE.

Explore the full profile